查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026712

全球外科移植市場：市場規模、佔有率和趨勢分析（2025-2032 年）

Surgical Graft Market Size, Share & Analysis | Global | 2025-2032 | Includes: Lower Limb Surgical Grafts, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 121 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球外科移植市場報告

2025年全球外科移植市場規模為2.06億美元。在預測期內，該市場預計將以0.6%的複合年成長率成長，到2032年將達到2.15億美元。

  • 這份關於全球外科移植市場的綜合報告涵蓋七個區域：北美、拉丁美洲、西歐、中東歐、中東、亞太地區和非洲。報告針對每個區域提供市場規模、銷售分析和平均售價數據，以及截至2032年的預測和截至2022年的歷史數據。與附件中的範例文件類似，本報告的結構相同，並根據外科移植市場的具體情況進行了調整，內容涵蓋執行摘要、市場動態、市場細分、競爭格局和可交付成果等。

本報告重點分析了全球外科移植物市場，包括銷售量、手術數量、平均售價、市場總值、市場佔有率、成長率和市場預測。報告還分析了市場促進因素和阻礙因素、近期併購、公司概況、產品系列和主要競爭對手。市場依適應症進一步細分為下肢、主動脈修復和非解剖繞道手術。

總體而言，將全球外科移植市場理解為一個穩定但受限的細分市場是恰當的。雖然它不再是血管介入治療領域的主要成長引擎，但對於某些手術和患者群體而言，它仍然是臨床必要的。因此，即使微創技術不斷改變血管治療的方式，市場仍具有重要的策略意義。

市場概覽

全球外科移植市場涵蓋用於開放性手術的合成血管移植物，這些移植物用於替換、繞過或重組病變血管。這些移植物應用於多種關鍵臨床場景，包括下肢繞道手術、主動脈修復和遠端旁路手術。當疾病的嚴重程度、解剖結構或患者的身體狀況限制了其他療法的應用時，通常會選擇外科移植。

該市場存在於一個快速變化的血管治療領域。過去，開放式血管手術在許多適應症中扮演更重要的角色。如今，越來越多的患者接受血管內治療，例如血管成形術、支架置入術和血管支架支架置入術。這些微創方法改變了轉診模式，重塑了治療流程，並減少了仍以開放性手術血管移植作為預設選擇的病例數。

然而，外科移植仍發揮重要作用，因為並非所有患者都適合血管內修復。有些患者病情嚴重、解剖結構複雜，或有限制血管支架、繞道手術或自體靜脈使用的臨床情況。在這些情況下，外科移植仍然是必要的。主動脈修復和某些下肢繞道手術尤其如此，因為這些手術需要持久的重組，而患者的解剖結構和疾病嚴重程度限制了治療選擇。

總體而言，全球外科移植市場受多種因素影響：對成熟手術的需求、特定的臨床需求以及來自新型血管技術的競爭壓力。這些因素共同解釋了為何該市場規模保持穩定，成長也較為溫和。

市場促進因素

血液透析患者

全球外科移植市場最重要的促進因素之一是血液透析患者數量的不斷成長。隨著全球需要長期透析的患者人數增加，對動靜脈（AV）通路外科移植的需求也不斷擴大。這些移植血管仍然是血管通路管理的關鍵組成部分，尤其適用於那些不適合動靜脈瘻管手術或因解剖因素導致其他通路選擇有限的患者。

這一因素尤其重要，因為動靜脈瘻管在歐洲許多地區已經非常普遍。由於動靜脈瘺已佔適宜病例的很大比例，因此動靜脈通路外科移植市場的進一步蠶食程度較以往更為有限。因此，外科移植將在血液透析領域中發揮更穩定的作用，尤其適用於那些通路需求複雜的患者。

動脈瘤發生率增加

動脈瘤發生率的不斷上升是另一個重要的市場促進因素。包括血管移植在內的外科手術通常僅限於病情較晚期的患者。在許多情況下，患者可選擇的血管內治療或旁路移植術有限，仍需要進行開放性手術進行修復。隨著世界人口老化，預計此類患者的數量將會增加。

人口老化推動了對主動脈修復和其他大型血運重組手術的需求。雖然血管內修復術已變得越來越普遍，但仍有相當數量的動脈瘤病例需要進行開放性手術血管移植。這將使外科血管移植市場在預測期內保持持續的需求。

降低醫療成本和提高成本意識

醫院和醫療保健系統的預算限制也支持了某些地區對外科移植的需求。在一些國家，尤其是在東歐部分地區，成本壓力減緩了血管支架的普及，人們更傾向於繼續使用價格較低的外科移植物。這並非因為外科手術更容易或創傷更小，而是因為使用血管支架帶來的總經濟負擔可能更高。

除了血管支架的高昂器械成本外，血管內修復通常還會產生後續費用，這可能會增加整體治療負擔。 EVAR I 試驗團隊提供的證據表明，血管內修復相關的總住院費用顯著高於開放性手術修復。在對價格敏感的醫療保健系統中，這種差異可能會影響治療方法選擇，並有助於維持外科移植手術的作用。

市場限制

其他血管內治療方法

全球外科移植市場最大的限制因素是血管內治療方法的激增。支架置入術和球囊血管成形術等微創治療方法，與完全外科手術相比，往往手術時間更短、病人負擔更輕、併發症更少。隨著這些血管內治療方法的不斷改進，對開放式外科移植的需求正在受到抑制。

這種影響在小腿手術中尤其顯著。無論是膝上或膝下病變，持續使用球囊和支架都會直接限制手術移植區域的生長。即使在開放性手術仍然有效的情況下，如果臨床條件允許，醫生和患者通常更傾向於選擇創傷較小的治療方法。

動脈粥狀硬化斑塊切除術裝置

動脈粥狀硬化斑塊切除術也是一個重要的抑制因素，因為它為某些斑塊相關疾病提供了比外科移植創傷更小的替代方案。機械、雷射和冷凍消融裝置正在拓展醫生可選擇的血管內治療方案，並減少直接進行外科移植修復的病例數。

這會影響市場成長和市場進入。隨著可採用動脈粥狀硬化斑塊切除術及相關血管內治療方法治療的病變類型不斷增加，需要嚴重依賴外科移植的公司和醫院將會減少。因此，外科移植的市佔率正在穩定萎縮，尤其是在下肢適應症方面。

自體靜脈移植

自體靜脈移植也限制了人工外科移植的市場滲透率。在下肢搭橋手術中，自體靜脈的長期通暢率通常高於合成移植物。當有合適的自體血管可用時，外科醫師往往更傾向於使用自體材料而非人工合成的移植物。

這是一個重要的限制因素，因為它減少了合成血管移植製造商在下肢領域可瞄準的病例數。然而，這種制約並非普遍存在。有些患者，特別是那些患有嚴重下肢缺血或血管品質差的患者，沒有合適的自體靜脈。在這種情況下，人工外科移植仍然必不可少。儘管如此，自體靜脈的使用仍限制了部分市場的成長潛力。

市場覆蓋範圍和數據範圍

定量範圍

市場規模、市佔率、市場預測、市場成長率、銷售量、平均售價。

定性範圍

市場促進因素和限制因素、市場規模和成長趨勢、近期併購、公司簡介、產品系列和主要競爭對手。

目標期

基準年：2025 年，歷史資料：截至 2022 年，預測：截至 2032 年。

按地區定位

北美洲、拉丁美洲、西歐、中歐和東歐、中東、亞太地區、非洲。

包含的資料類型

銷售量、平均售價、治療次數、市場規模和成長趨勢。

本報告旨在透過結合價格和銷售分析以及開放式血管修復如何融入血管治療的更廣泛發展策略背景，為全球外科移植市場提供可操作的觀點。

目標市場及區隔

  • 本報告涵蓋全球外科移植市場，並依適應症進一步細分如下：

下肢外科移植市場

此部分包括用於下肢旁路手術和相關周圍血管重建術的移植物。

主動脈修復外科移植物市場

此部分包括用於開放式主動脈修復的移植物，包括動脈瘤及相關疾病的大規模重組。

用於解剖搭橋手術的外科移植市場。

此部分包括用於旁路手術的移植血管，用於將血液流向正常解剖路徑之外。

每個細分市場均以銷售量、平均售價和市場總值進行分析，並包含截至 2032 年的預測數據和截至 2022 年的歷史數據。這種細分反映了人工外科移植繼續發揮重要作用的關鍵臨床應用領域。

競爭分析

2025年，WL Gore在全球外科移植物市場，尤其是在膝上和膝下外科移植物領域，確立了穩固的地位。該公司推出的PROPATEN血管移植物憑藉其獨特的設計、卓越的成本效益和可靠的臨床證據，獲得了廣泛的認可。肝素塗層有助於抑制移植物表面的血栓形成，增強了醫生的信心，並提升了產品的優異性能，尤其是在膝下血管移植領域。

泰爾茂憑藉其“Gelsoft”和“Gelweave”產品線，仍然是市場上的主要競爭對手。這些器械採用可水解明膠作為塗層，「Gelsoft」由密封聚酯製成，「Gelweave」由編織聚酯製成。泰爾茂豐富的產品系列支持心臟和周邊血管介入應用，使其在各種血管環境中擁有柔軟性和高度的手術適應性。在不同的開放手術修復病例需要不同特性的移植物的情況下，其廣泛的產品線仍然是其市場優勢。

Maquet公司也是行業領導參與企業，尤其是在腹部主動脈血管瘤修復領域。其HEMASHIELD產品系列是市場上最知名的AAA移植物平台之一。 HEMASHIELD Gold以其高通暢率和優異的生物相容性而聞名，而HEMASHIELD Platinum則採用紡織分支移植物設計，具有成熟的癒合性能和長期療效。此外，該公司還提供一系列肝素塗層、抗菌和膠原蛋白塗層移植物，進一步鞏固了其市場地位。

整體而言，外科移植市場的競爭格局受材料技術、塗層策略、長期通暢率以及滿足各種手術適應症的能力所影響。由於這是一個成熟的市場，其競爭力更依賴臨床成功案例、值得信賴的產品組合以及與醫院的長期合作關係，而非創新。

科技和醫療治療的發展趨勢

外科移植市場最顯著的趨勢之一是向血管內和微創治療的廣泛轉變。隨著血管支架和其他血管內裝置的不斷發展，它們持續重塑血管治療的路徑，並在某些適應症中減少了開放性手術的數量。

在外科移植片市場內部，塗層技術仍是一項關鍵的差異化因素。肝素塗層、膠原蛋白塗層和抗菌移植物透過解決血栓症風險、癒合性能和感染等方面的問題，持續提升產品定位。

另一個重要趨勢是適應症的選擇。外科移植手術擴大僅限於經血管治療方法不適用的病例，這意味著市場正從常規血管治療轉向專注於晚期疾病和特定患者群體。

最後，成本仍然是當前趨勢背後的主要驅動力。在預算壓力較大的地區，外科移植手術仍具有成本低於許多高階血管內治療方法的優勢，尤其是在考慮後續費用的情況下。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

報告包含詳細的市場分析、區域洞察和預測數據，共 137 頁。

附錄：調查方法和縮寫詞彙表。

這份報告的意義

到 2032 年，全球外科移植市場中最穩定的機會在哪裡？

血管內治療的替代方案如何影響下肢、主動脈修復和解剖範圍外旁路移植的需求？

血液透析的增加和動脈瘤的盛行率上升對維持市場有何影響？

醫院預算限制和血管內修復的總成本如何影響治療方法方案的選擇？

在主要的接枝材料類別中，哪些競爭對手佔據了最強的地位？此外，他們的產品塗層技術有何差異化優勢？

在臨床需求依然旺盛、市場競爭日益激烈的背景下，供應商該如何規劃成長？

iData Research 的《全球外科移植物市場報告》透過詳細的市場區隔、定價分析、競爭資訊和市場預測，解答了這些問題。您可以利用這份報告對標競爭對手、評估區域需求，並在這個成熟但仍重要的血管器械領域制定策略。

目錄

圖表清單

調查方法

  • 第一步：計劃啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟 3：設計和準備訪談和調查問卷。
  • 第四步：進行初步調查
  • 第五步：調查與分析：建立基準估計值
  • 第六步：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟九：客戶回饋與市場監測

全球關稅的影響

外科移植市場

  • 執行摘要
    • 全球外科移植市場概覽
    • 競爭分析
    • 目標程式
    • 目標市場
    • 目標區域
  • 介紹
  • 手術次數
    • 全外科移植手術
    • 下肢外科移植手術
    • 主動脈修復手術（移植手術）
    • 解剖額外通路繞道手術及移植
  • 市場概覽
    • 按細分市場
    • 按地區
  • 市場分析與預測
    • 整體外科移植市場
    • 下肢外科移植市場
    • 主動脈修復外科移植物市場
    • 用於體外搭橋手術的移植物市場。
  • 促進因素和抑制因素
  • 競爭性市佔率分析

簡稱

Product Code: iDATA_GLCPV26_SG_MC

Global Surgical Graft Market Report

The global surgical graft market was valued at $206 million in 2025. Over the forecast period, the market is expected to grow at a CAGR of 0.6% to reach $215 million by 2032.

  • The full report suite on the global market for surgical grafts covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides market valuation, unit analysis and average selling price data, along with forecasts through 2032 and historical data to 2022. As with the attached example document, this description follows the same structured sequence from executive summary through market dynamics, segmentation, competition and deliverables, adapted to the specific conditions of the surgical graft market .

This report provides a focused analysis of the global surgical graft market, including unit sales, procedure numbers, average selling prices, total market value, market shares, growth rates and market forecasts. It also includes market drivers and limiters, recent mergers and acquisitions, company profiles, product portfolios and analysis of leading competitors. The market is further segmented by indication into lower limb, aorta repair and extra-anatomical bypass procedures.

Overall, the global surgical graft market is best understood as a stable but constrained segment. It is no longer a major growth engine within vascular intervention, but it remains clinically necessary in selected procedures and patient populations. That gives the market ongoing strategic importance even as minimally invasive techniques continue reshaping vascular care.

Market Overview

The global surgical graft market includes synthetic vascular grafts used in open surgical procedures to replace, bypass or reconstruct diseased blood vessels. These grafts are used in several major clinical settings, including lower-limb bypass, aortic repair and extra-anatomical bypass procedures. In many of these cases, surgical grafts are selected when disease severity, anatomy or patient condition limits the use of alternative therapies.

This market exists within a vascular treatment landscape that has changed significantly over time. In earlier periods, open vascular surgery played a much larger role across many indications. Today, a growing number of patients are treated using endovascular methods such as angioplasty, stenting and stent graft placement. These minimally invasive approaches have changed referral patterns, altered treatment algorithms and reduced the number of cases in which open surgical graft implantation is the default option.

Even so, surgical grafts remain relevant because not all patients are good candidates for endovascular repair. Some present with advanced disease, difficult anatomy or clinical circumstances that limit the use of stent grafts, bypass alternatives or autologous veins. In these cases, surgical grafts remain necessary. This is especially true in aortic repair and in selected lower-limb bypass procedures where durable reconstruction is required and where the patient's anatomy or disease burden narrows the treatment options.

Overall, the global surgical graft market reflects a combination of mature procedural demand, selective clinical necessity and competitive pressure from newer vascular technologies. That combination explains why the market continues to exist with steady value, but only modest growth.

Market Drivers

Hemodialysis Patients

One of the most important drivers in the global surgical graft market is the growing population of hemodialysis patients. As the number of patients requiring long-term dialysis increases worldwide, demand for AV access surgical grafts also grows. These grafts remain an important part of access management, particularly in patients who are not suitable candidates for fistula creation or whose anatomy limits other access options.

This driver is especially important because fistula placement has already reached high penetration in much of Europe. Since fistulas have already taken a large share of appropriate cases, further cannibalization of the AV access surgical graft market is more limited than it was in earlier periods. That leaves surgical grafts with a more stable role in the hemodialysis setting, particularly in patients with more complex access needs.

Increased Prevalence of Aneurysms

The increasing prevalence of aneurysms is another important market driver. Surgical interventions, including vascular graft implantation, are often reserved for patients with more advanced disease states. In many of these cases, patients have limited endovascular or bypass graft options and still require open repair. As the global population continues to age, the number of patients who fall into this category is expected to increase.

This aging effect supports demand in aortic repair and other major vascular reconstruction procedures. Even though endovascular repair has become more common, open surgical graft implantation remains necessary in a meaningful subset of aneurysm cases. This provides continued procedural support for the surgical graft market over the forecast period.

Healthcare Spending Cuts and Cost Sensitivity

Budget constraints in hospitals and health systems also support demand for surgical grafts in certain regions. In several countries, especially in parts of Eastern Europe, cost pressure has slowed the adoption of stent grafts and favored the continued use of less expensive surgical grafts. This is not because surgical procedures are easier or less invasive, but because the total economic burden of stent graft use can be higher.

In addition to the higher device cost of stent grafts, endovascular repair often carries follow-up costs that can add to the overall treatment burden. Evidence from teams involved in the EVAR I trial showed that total hospital costs associated with endovascular repair were significantly higher than those associated with open repair. In price-sensitive healthcare systems, this difference can influence treatment choice and help preserve the role of surgical grafts.

Market Limiters

Alternative Endovascular Procedures

The biggest limiter in the global surgical graft market is the availability of alternative endovascular procedures. Stent placement and balloon angioplasty offer less invasive treatment paths and are associated with shorter procedure times, lower patient trauma and often fewer complications than full surgical repair. As these endovascular approaches continue improving, they limit demand for open surgical graft procedures.

This effect is especially visible in lower-leg procedures. In above-the-knee and below-the-knee disease, the continued use of balloons and stents directly constrains the growth of surgical graft segments. Even in cases where open surgery remains viable, physicians and patients often prefer less invasive approaches when clinically appropriate.

Atherectomy Devices

Atherectomy is another important limiter because it provides a minimally invasive alternative to surgical graft implantation in selected plaque-related disease. Mechanical, laser and cryoplasty-based debulking devices have expanded the range of endovascular options available to physicians, which reduces the number of cases moving directly to surgical graft repair.

This affects both market growth and market participation. As more lesion types become manageable with atherectomy and related endovascular methods, fewer companies and fewer hospitals need to rely heavily on surgical graft procedures. This steadily narrows the role of the market, especially in lower-limb applications.

Autologous Vein Grafts

Autologous vein grafts also limit the penetration of synthetic surgical grafts. In lower-limb bypass procedures, autologous veins often provide better long-term patency than synthetic alternatives. When suitable native vessels are available, surgeons may prefer autologous material rather than a manufactured graft.

This is a meaningful limitation because it reduces the number of cases available to synthetic graft manufacturers in the lower-limb segment. However, this constraint is not universal. Some patients, especially those with critical limb ischemia or with poor vessel quality, do not have suitable native veins. In those cases, synthetic surgical grafts remain necessary. Still, autologous vein use continues to cap growth potential in parts of the market.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Qualitative Coverage

Market drivers and limiters, market size and growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Time Frame

Base year 2025, historical data to 2022 and forecasts through 2032.

Regional Coverage

North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa.

Data Types Included

Unit sales, average selling prices, procedure numbers, market size and growth trends.

This report is designed to give a practical view of the global surgical graft market by combining pricing and volume analysis with strategic context on how open vascular repair fits into the broader evolution of vascular treatment.

Markets Covered and Segmentation

  • The report covers the Global Surgical Graft Market, further segmented by indication into:

Lower Limb Surgical Graft Market

This segment includes grafts used in lower-extremity bypass and related peripheral vascular reconstruction procedures.

Aorta Repair Surgical Graft Market

This segment includes grafts used in open aortic repair procedures, including major reconstruction in aneurysm and related disease cases.

Extra-Anatomical Bypass Surgical Graft Market

This segment includes grafts used in bypass procedures that reroute blood flow outside the normal anatomical pathway.

Each segment is analyzed using unit sales, average selling prices and total market value, with forecasts through 2032 and historical data to 2022. This segmentation reflects the key clinical use areas in which synthetic surgical grafts continue to play a relevant role.

Competitive Analysis

W.L. Gore held a strong position in the global surgical graft market in 2025, particularly in above-the-knee and below-the-knee surgical grafts. Its PROPATEN vascular graft gained strong traction due to a combination of distinctive design attributes, cost-effectiveness and solid clinical evidence. The heparin coating helps reduce thrombus formation on the graft surface, which supports physician confidence and contributes to the product's strong performance, especially in the below-the-knee subsegment.

Terumo remains another major competitor through its Gelsoft and Gelweave product lines. These devices use hydrolyzable gelatin in the coating, with Gelsoft made from sealed polyester and Gelweave made from woven polyester. Terumo's broad portfolio supports use across both cardiac and peripheral applications, giving the company flexibility and strong procedural relevance in multiple vascular settings. Its product breadth remains an advantage in a market where different open repair cases demand different graft characteristics.

Maquet is also a leading participant, especially in abdominal aortic aneurysm repair. Its HEMASHIELD product family remains among the most recognized AAA graft platforms in the market. HEMASHIELD Gold is known for high patency rates and improved biocompatibility, while HEMASHIELD Platinum offers a woven branch graft design with established healing performance and long-term effectiveness. The company also supports its market position with an extensive range of heparin-coated, antimicrobial and collagen-coated graft options.

Overall, the competitive landscape in the surgical graft market is shaped by material technology, coating strategy, long-term patency performance and the ability to serve different procedural indications. This is a mature market, so competitive strength depends less on disruption and more on clinical track record, trusted product families and sustained hospital relationships.

Technology and Practice Trends

One of the clearest trends in the surgical graft market is the broader shift toward endovascular and minimally invasive treatment. As stent grafts and other endovascular tools improve, they continue to reshape the vascular care pathway and reduce the number of open procedures in some indications.

Within the surgical graft market itself, coating technologies remain an important area of differentiation. Heparin-coated, collagen-coated and antimicrobial grafts continue to support product positioning by addressing thrombosis risk, healing performance and infection-related concerns.

Another important trend is procedural selectivity. Surgical grafts are increasingly reserved for cases where endovascular alternatives are less suitable, which means the market is becoming more concentrated around advanced disease states and specific patient populations rather than routine vascular treatment.

Finally, cost remains a practical trend driver. In regions with stronger budget pressure, surgical grafts continue to benefit from being less expensive than many premium endovascular alternatives, especially when follow-up costs are considered.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

137 pages of detailed market analysis, regional discussion and forecast data.

Methodology Appendix and Acronym Glossary.

Why This Report

Where are the most stable opportunities in the global surgical graft market through 2032?

How are endovascular alternatives affecting lower-limb, aortic repair and extra-anatomical bypass graft demand?

What role do hemodialysis growth and aneurysm prevalence play in sustaining the market?

How do hospital budget pressures and the total cost of endovascular repair influence treatment choice?

Which competitors hold the strongest positions in key graft categories, and how are product coatings shaping differentiation?

How can suppliers plan for growth in a market that remains clinically necessary but increasingly selective?

The Global Surgical Graft Market Report from iData Research answers these questions with detailed segmentation, pricing analysis, competitive intelligence and market forecasting. Use it to benchmark competitors, evaluate regional demand and support strategy in a mature but still important vascular device category.

TABLE OF CONTENT

List Of Figures

List Of Charts

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Surgical Graft Market

  • 10.1 Executive Summary
    • 10.1.1 Global Surgical Graft Market Overview
    • 10.1.2 Competitive Analysis
    • 10.1.3 Procedures Included
    • 10.1.4 Markets Included
    • 10.1.5 Regions Included
  • 10.2 Introduction
  • 10.3 Procedure Numbers
    • 10.3.1 Total Surgical Graft Procedures
    • 10.3.2 Lower-Limb Surgical Graft Procedures
    • 10.3.3 Aorta Repair Surgical Graft Procedures
    • 10.3.4 Extra-Anatomical Bypass Surgical Graft Procedures
  • 10.4 Market Overview
    • 10.4.1 By Segment
    • 10.4.2 By Region
  • 10.5 Market Analysis And Forecast
    • 10.5.1 Total Surgical Graft Market
    • 10.5.2 Lower-Limb Surgical Graft Market
    • 10.5.3 Aorta Repair Surgical Graft Market
      • 10.5.3.1 Aaa Surgical Graft Market
    • 10.5.4 Extra-Anatomical Bypass Surgical Graft Market
  • 10.6 Drivers And Limiters
    • 10.6.1 Market Drivers
    • 10.6.2 Market Limiters
  • 10.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 10-1: Surgical Graft Market, Global, 2025 & 2032
  • Chart 10-2: Surgical Graft Procedures, Global, 2025
  • Chart 10-3: Surgical Graft Procedures by Region, Global, 2022 - 2032
  • Chart 10-4: Surgical Graft Market by Segment, Global, 2022 - 2032
  • Chart 10-5: Surgical Graft Market by Region, Global, 2022 - 2032
  • Chart 10-6: Leading Competitors, Surgical Graft Market, Global, 2025

LIST OF FIGURES

  • Figure 10-1: Surgical Graft Procedures Covered
  • Figure 10-2: Surgical Graft Markets Covered
  • Figure 10-3: Surgical Graft Regions Covered, Global (1 of 2)
  • Figure 10-4: Surgical Graft Regions Covered, Global (2 of 2)
  • Figure 10-5: Surgical Graft Procedures by Segment, Global, 2022 - 2032
  • Figure 10-6: Surgical Graft Procedures by Region, Global, 2022 - 2032
  • Figure 10-7: Surgical Graft Procedures by Country, North America, 2022 - 2032
  • Figure 10-8: Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 10-9: Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 10-10: Surgical Graft Procedures by Country, Western Europe, 2022 - 2032
  • Figure 10-11: Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 10-12: Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 10-13: Surgical Graft Procedures by Country, Middle East, 2022 - 2032
  • Figure 10-14: Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 10-15: Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 10-16: Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 10-17: Surgical Graft Procedures by Country, Africa, 2022 - 2032
  • Figure 10-18: Lower-Limb Surgical Graft Procedures by Region, Global, 2022 - 2032
  • Figure 10-19: Lower-Limb Surgical Graft Procedures by Country, North America, 2022 - 2032
  • Figure 10-20: Lower-Limb Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 10-21: Lower-Limb Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 10-22: Lower-Limb Surgical Graft Procedures by Country, Western Europe, 2022 - 2032
  • Figure 10-23: Lower-Limb Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 10-24: Lower-Limb Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 10-25: Lower-Limb Surgical Graft Procedures by Country, Middle East, 2022 - 2032
  • Figure 10-26: Lower-Limb Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 10-27: Lower-Limb Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 10-28: Lower-Limb Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 10-29: Lower-Limb Surgical Graft Procedures by Country, Africa, 2022 - 2032
  • Figure 10-30: Aorta Repair Surgical Graft Procedures by Segment, Global, 2022 - 2032
  • Figure 10-31: Aorta Repair Surgical Graft Procedures by Region, Global, 2022 - 2032
  • Figure 10-32: Aorta Repair Surgical Graft Procedures by Country, North America, 2022 - 2032
  • Figure 10-33: Aorta Repair Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 10-34: Aorta Repair Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 10-35: Aorta Repair Surgical Graft Procedures by Country, Western Europe, 2022 - 2032
  • Figure 10-36: Aorta Repair Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 10-37: Aorta Repair Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 10-38: Aorta Repair Surgical Graft Procedures by Country, Middle East, 2022 - 2032
  • Figure 10-39: Aorta Repair Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 10-40: Aorta Repair Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 10-41: Aorta Repair Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 10-42: Aorta Repair Surgical Graft Procedures by Country, Africa, 2022 - 2032
  • Figure 10-43: AAA Surgical Graft Procedures by Region, Global, 2022 - 2032
  • Figure 10-44: AAA Surgical Graft Procedures by Country, North America, 2022 - 2032
  • Figure 10-45: AAA Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 10-46: AAA Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 10-47: AAA Surgical Graft Procedures by Country, Western Europe, 2022 - 2032
  • Figure 10-48: AAA Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 10-49: AAA Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 10-50: AAA Surgical Graft Procedures by Country, Middle East, 2022 - 2032
  • Figure 10-51: AAA Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 10-52: AAA Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 10-53: AAA Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 10-54: AAA Surgical Graft Procedures by Country, Africa, 2022 - 2032
  • Figure 10-55: TAA Surgical Graft Procedures by Region, Global, 2022 - 2032
  • Figure 10-56: TAA Surgical Graft Procedures by Country, North America, 2022 - 2032
  • Figure 10-57: TAA Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 10-58: TAA Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 10-59: TAA Surgical Graft Procedures by Country, Western Europe, 2022 - 2032
  • Figure 10-60: TAA Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 10-61: TAA Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 10-62: TAA Surgical Graft Procedures by Country, Middle East, 2022 - 2032
  • Figure 10-63: TAA Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 10-64: TAA Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 10-65: TAA Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 10-66: TAA Surgical Graft Procedures by Country, Africa, 2022 - 2032
  • Figure 10-67: Extra-Anatomical Bypass Surgical Graft Procedures by Region, Global, 2022 - 2032
  • Figure 10-68: Extra-Anatomical Bypass Surgical Graft Procedures by Country, North America, 2022 - 2032
  • Figure 10-69: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 10-70: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 10-71: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Western Europe, 2022 - 2032
  • Figure 10-72: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 10-73: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 10-74: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Middle East, 2022 - 2032
  • Figure 10-75: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 10-76: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 10-77: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 10-78: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Africa, 2022 - 2032
  • Figure 10-79: Surgical Graft Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 10-80: Surgical Graft Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 10-81: Total Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-82: Units Sold by Region, Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-83: Average Selling Price by Region, Surgical Graft Market, Global, 2022 - 2032 (US$)
  • Figure 10-84: Market Value by Region, Surgical Graft Market, Global, 2022 - 2032 (US$M)
  • Figure 10-85: Lower-Limb Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-86: Units Sold by Region, Lower-Limb Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-87: Average Selling Price by Region, Lower-Limb Surgical Graft Market, Global, 2022 - 2032 (US$)
  • Figure 10-88: Market Value by Region, Lower-Limb Surgical Graft Market, Global, 2022 - 2032 (US$M)
  • Figure 10-89: Aorta Repair Surgical Graft Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 10-90: Total Aorta Repair Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-91: Units Sold by Region, Aorta Repair Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-92: Average Selling Price by Region, Aorta Repair Surgical Graft Market, Global, 2022 - 2032 (US$)
  • Figure 10-93: Market Value by Region, Aorta Repair Surgical Graft Market, Global, 2022 - 2032 (US$M)
  • Figure 10-94: AAA Surgical Graft Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-95: Units Sold by Region, AAA Surgical Graft Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-96: Average Selling Price by Region, AAA Surgical Graft Surgical Graft Market, Global, 2022 - 2032 (US$)
  • Figure 10-97: Market Value by Region, AAA Surgical Graft Surgical Graft Market, Global, 2022 - 2032 (US$M)
  • Figure 10-98: TAA Surgical Graft Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-99: Units Sold by Region, TAA Surgical Graft Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-100: Average Selling Price by Region, TAA Surgical Graft Surgical Graft Market, Global, 2022 - 2032 (US$)
  • Figure 10-101: Market Value by Region, TAA Surgical Graft Surgical Graft Market, Global, 2022 - 2032 (US$M)
  • Figure 10-102: Extra-Anatomical Bypass Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-103: Units Sold by Region, Extra-Anatomical Bypass Surgical Graft Market, Global, 2022 - 2032
  • Figure 10-104: Average Selling Price by Region, Extra-Anatomical Bypass Surgical Graft Market, Global, 2022 - 2032 (US$)
  • Figure 10-105: Market Value by Region, Extra-Anatomical Bypass Surgical Graft Market, Global, 2022 - 2032 (US$M)
  • Figure 10-106: Leading Competitors, Surgical Graft Market, Global, 2025